Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

47.96
+0.30640.64%
Volume:3.89M
Turnover:186.74M
Market Cap:97.73B
PE:13.43
High:48.38
Open:47.83
Low:47.78
Close:47.65
52wk High:51.46
52wk Low:32.38
Shares:2.04B
Float Shares:1.95B
Volume Ratio:0.91
T/O Rate:0.20%
Dividend:1.72
Dividend Rate:3.58%
EPS(TTM):3.57
EPS(LYR):1.58
ROE:41.52%
ROA:7.13%
PB:4.51
PE(LYR):30.33

Loading ...

GSK and Alector Phase 3 Dementia Trial Ends Early: What Investors Need to Know

TIPRANKS
·
2 hours ago

UBS Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

PRESS DIGEST-British Business - January 21

Reuters
·
Yesterday

Top Midday Gainers

MT Newswires Live
·
Yesterday

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

GSK, Shionogi reach agreement with Pfizer for interest in ViiV Healthcare

TIPRANKS
·
Jan 20

Top Premarket Gainers

MT Newswires Live
·
Jan 20

This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. -- Barrons.com

Dow Jones
·
Jan 20

How Greenland could turn into a Big Tech problem, according to Morgan Stanley's Mike Wilson

Dow Jones
·
Jan 20

GSK's Tesaro Licenses Alteogen Enzyme Technology

MT Newswires Live
·
Jan 20

GSK to acquire US biotech group for $2.2bn

cityam
·
Jan 20

GSK to acquire Rapt Therapeutics for $58.00 per share

TIPRANKS
·
Jan 20

Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Jan 20

Dow Jones Top Company Headlines at 3 AM ET: GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments | Baidu's ...

Dow Jones
·
Jan 20

GSK to Buy RAPT Therapeutics in $2.2 Billion Deal for Promising Food Allergy Therapy

Reuters
·
Jan 20

GSK - Pfizer to Receive $1.875 Bn, GSK Special Dividend of $0.250 Bn

THOMSON REUTERS
·
Jan 20

GSK - Deal Completion Expected in Q1 2026, Subject to Regulatory Clearances

THOMSON REUTERS
·
Jan 20

GSK - Viiv Healthcare to Issue New Shares to Shionogi for $2.125 Bn

THOMSON REUTERS
·
Jan 20

GSK - Shionogi Increases Holding to 21.7%, GSK Maintains 78.3% in Viiv

THOMSON REUTERS
·
Jan 20

GSK price target raised to 1,675 GBp from 1,600 GBp at Deutsche Bank

TIPRANKS
·
Jan 17